-
-
-
-
-
-
-
TG Therapeutics reports $616M 2025 revenue, targets $875-900M for 2026
-
-
-
-
-
-
-
TG Therapeutics (TGTX) call put ratio 1 call to 1.5 puts with a focus on July 40 calls as share price up 1.3%
-
-
-
-
-
-
-
TG Therapeutics (TGTX) Announces Two Publications Highlighting BRIUMVI in Medical Journals
-
-
-
-
-
-
-
TG Therapeutics (TGTX) Tops Q4 EPS by 7c, provides outlook
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on TG Therapeutics (TGTX)
-
-
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

